Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Inès de Dinechin to replace Laurent Seyer as Lyxor A.M. CEO

Thursday, February 02, 2012
Opalesque Industry Update - Societe Generale Corporate & Investment Banking announces the appointment of Inès de Dinechin as Chief Executive Officer of Lyxor Asset Management. She replaces Laurent Seyer who will leave Societe Generale group to pursue other opportunities. This appointment will be effective as of the end of March 2012.

Inès de Dinechin has spent the vast majority of her career in markets activities, holding several management positions in financial markets (engineering and derivatives product sales) before being appointed Global Head of Fixed Income Structured Products (Rates, Forex, Credit). Her experience constitutes a real asset to consolidate the leadership of Lyxor Asset Management in its four areas of expertise: alternative investments, indexing & ETFs, quantitative and structured investments.

Inès de Dinechin’s replacement as Societe Generale Corporate & Investment Banking Head of Human Resources will be announced at a later stage.

Biography
Inès de Dinechin is named CEO of Lyxor Asset Management as of the end of March 2012.

Inès de Dinechin joined Societe Generale Corporate & Investment Banking markets activities in 1991. In charge of Derivatives Sales for French Corporates from 1994, she successively headed French and international teams until 2008. In 1999, she was given additional responsibility for the Fixed Income dealing room in Frankfurt and was also co-head of the Interest Rates Financial Engineering from 2002 to 2004. In 2008, she was appointed Global Head of Fixed Income Structured Products (Rates, Forex, Credit). She was named Head of Human Resources for Societe Generale Corporate & Investment Banking in 2009 and also became a member of Societe Generale Corporate & Investment Banking’s extended Executive Committee. Inès de Dinechin has a degree in Economics (Paris IX- Dauphine) and a Market Finance MBA (IEP Paris).

(press release)

Société Générale Corporate & Investment Banking www.sgcib.com

Lyxor Asset Management www.lyxor.com

BG

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its